Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 326

1.

[Uropathology].

Hartmann A, Knüchel-Clarke R, Kristiansen G.

Pathologe. 2016 Jan 28. [Epub ahead of print] German. No abstract available.

PMID:
26821327
2.

[The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].

Kristiansen G, Egevad L, Amin M, Delahunt B, Srigley JR, Humphrey PA, Epstein JI; Graduierungskommittee.

Pathologe. 2016 Jan 26. [Epub ahead of print] German.

PMID:
26809207
4.

[Intraductal carcinoma of the prostate].

Kristiansen G, Varma M, Seitz G.

Pathologe. 2016 Jan 18. [Epub ahead of print] German.

PMID:
26782033
5.

Prognostic Significance and Functional Role of CEP57 in Prostate Cancer.

Mang J, Korzeniewski N, Dietrich D, Sailer V, Tolstov Y, Searcy S, von Hardenberg J, Perner S, Kristiansen G, Marx A, Roth W, Herpel E, Grüllich C, Popeneciu V, Pahernik S, Hadaschik B, Hohenfellner M, Duensing S.

Transl Oncol. 2015 Dec;8(6):487-96. doi: 10.1016/j.tranon.2015.11.004.

6.

Tissue Microdissection.

Rabien A, Kristiansen G.

Methods Mol Biol. 2016;1381:39-52. doi: 10.1007/978-1-4939-3204-7_2.

PMID:
26667453
7.

Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score- specific metabolomic alterations in prostate cancer.

Meller S, Meyer HA, Bethan B, Dietrich D, González Maldonado S, Lein M, Montani M, Reszka R, Schatz P, Peter E, Stephan C, Jung K, Kamlage B, Kristiansen G.

Oncotarget. 2015 Nov 23. doi: 10.18632/oncotarget.6370. [Epub ahead of print]

8.

Low-level APC mutational mosaicism is the underlying cause in a substantial fraction of unexplained colorectal adenomatous polyposis cases.

Spier I, Drichel D, Kerick M, Kirfel J, Horpaopan S, Laner A, Holzapfel S, Peters S, Adam R, Zhao B, Becker T, Lifton RP, Perner S, Hoffmann P, Kristiansen G, Timmermann B, Nöthen MM, Holinski-Feder E, Schweiger MR, Aretz S.

J Med Genet. 2015 Nov 27. pii: jmedgenet-2015-103468. doi: 10.1136/jmedgenet-2015-103468. [Epub ahead of print]

PMID:
26613750
9.

Long-Term Analysis of Ab-2 (Clone SN3b) Immunoreactivity as a Prognostic Factor in Breast Carcinoma.

Winzer KJ, Bellach J, Kristiansen G.

Breast Care (Basel). 2015 Aug;10(4):273-6. doi: 10.1159/000377654. Epub 2015 Mar 26.

10.

TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomy.

Berg KD, Soldini D, Jung M, Dietrich D, Stephan C, Jung K, Dietel M, Vainer B, Kristiansen G.

Virchows Arch. 2015 Nov 21. [Epub ahead of print]

PMID:
26590985
11.

Membranous CD24 expression as detected by the monoclonal antibody SWA11 is a prognostic marker in non-small cell lung cancer patients.

Majores M, Schindler A, Fuchs A, Stein J, Heukamp L, Altevogt P, Kristiansen G.

BMC Clin Pathol. 2015 Nov 16;15:19. doi: 10.1186/s12907-015-0019-z. eCollection 2015.

12.

The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer.

Gevensleben H, Dietrich D, Golletz C, Steiner S, Jung M, Thiesler T, Majores M, Stein J, Uhl B, Müller S, Ellinger J, Stephan C, Jung K, Brossart P, Kristiansen G.

Clin Cancer Res. 2015 Nov 16. [Epub ahead of print]

PMID:
26573597
13.

The Distinct Gene Regulatory Network of Myoglobin in Prostate and Breast Cancer.

Bicker A, Brahmer AM, Meller S, Kristiansen G, Gorr TA, Hankeln T.

PLoS One. 2015 Nov 11;10(11):e0142662. doi: 10.1371/journal.pone.0142662. eCollection 2015.

14.

Prognostic relevance of proliferation markers (Ki-67, PHH3) within the cross-relation of ERG translocation and androgen receptor expression in prostate cancer.

Goltz D, Montani M, Braun M, Perner S, Wernert N, Jung K, Dietel M, Stephan C, Kristiansen G.

Pathology. 2015 Dec;47(7):629-36. doi: 10.1097/PAT.0000000000000320.

PMID:
26517642
15.

[What do our clients want? : Is speed all that matters?]

Fronhoffs F, Thiesler T, Kristiansen G.

Pathologe. 2015 Sep 1. [Epub ahead of print] German.

PMID:
26324518
16.

Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer.

Latz S, Umbach T, Goltz D, Kristiansen G, Müller SC, Ellinger J.

Urol Int. 2016;96(1):39-45. doi: 10.1159/000438868. Epub 2015 Aug 20.

PMID:
26287745
17.

PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer.

Puhr M, Hoefer J, Eigentler A, Dietrich D, van Leenders G, Uhl B, Hoogland M, Handle F, Schlick B, Neuwirt H, Sailer V, Kristiansen G, Klocker H, Culig Z.

Oncogene. 2015 Aug 10. doi: 10.1038/onc.2015.292. [Epub ahead of print]

PMID:
26257066
18.

Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype.

Scholl UI, Healy JM, Thiel A, Fonseca AL, Brown TC, Kunstman JW, Horne MJ, Dietrich D, Riemer J, Kücükköylü S, Reimer EN, Reis AC, Goh G, Kristiansen G, Mahajan A, Korah R, Lifton RP, Prasad ML, Carling T.

Clin Endocrinol (Oxf). 2015 Dec;83(6):779-89. doi: 10.1111/cen.12873. Epub 2015 Sep 23.

PMID:
26252618
19.

Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma.

Schäfer MH, Lingohr P, Sträßer A, Lehnen NC, Braun M, Perner S, Höller T, Kristiansen G, Kalff JC, Gütgemann I.

Hum Pathol. 2015 Oct;46(10):1488-95. doi: 10.1016/j.humpath.2015.06.007. Epub 2015 Jun 23.

PMID:
26239623
20.

BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma.

Nettersheim D, Jostes S, Sharma R, Schneider S, Hofmann A, Ferreira HJ, Hoffmann P, Kristiansen G, Esteller MB, Schorle H.

PLoS Genet. 2015 Jul 30;11(7):e1005415. doi: 10.1371/journal.pgen.1005415. eCollection 2015 Jul.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk